Centocor sells UK plant to Trinity Biotech
This article was originally published in Clinica
Executive Summary
Centocor, the US biotech company, has sold its UK diagnostic test factory to Trinity Biotech for $5.5 million. The plant, in Guildford, Surrey, develops and manufactures infectious disease tests in microtitre EIA (enzyme immunoassay) plate format. These include tests for rubella, herpes, syphilis and a recently developed test for Chagas disease. The business had a turnover of $3.2 million in 1996.